Labcorp (LH) Q3 2025 10-Q Quarterly Report
Labcorp (LH) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 31, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Labcorp Q3 2025 10-Q Analysis
Management Discussion & Analysis
- • Revenue $3.56B Q3 FY25, up 8.6% YoY from $3.28B; organic growth 6.2%, acquisitions 1.7%, currency 0.7%
- • Operating margin Q3 FY25: Dx 16.3% vs 15.2% YoY, BLS 16.5% vs 16.4% YoY; total operating income $396.6M up 56.1% YoY
- • Best segment Dx: operating income $450.4M up 16.3%, worst relative margin change BLS: 16.5% up only 0.2%
- • Cash and equivalents $598.1M at Q3 FY25, down from $1.52B YoY; operating cash flow $1.03B up from $808.6M; $1.17B cash used in financing, including increased stock repurchases
- • Management notes potential revenue risk from new US healthcare law (OBBBA) but expects no material impact; expects ongoing compliance with debt covenants and sufficient liquidity
Risk Factors
- • No material changes in risk factors from 2024 10-K carried forward
- • Pandemic impact risk persists with potential lab test volume fluctuations
- • Regulatory compliance risk from evolving healthcare laws maintained without update
- • Competitive pressure from new diagnostic entrants remains a key market risk
- • Financial risk includes ongoing liquidity management amid capital expenditure demands
Labcorp Q3 2025 Quarterly FinancialsXBRL
Revenue
$3.6B
▲ +8.6% YoY▲ +1.0% QoQ
Net Income
$261M
▲ +54.2% YoY▲ +9.8% QoQ
Gross Margin
28.8%
▲ +121bp YoY▼ -89bp QoQ
Operating Margin
11.1%
▲ +339bp YoY▼ -5bp QoQ
Net Margin
7.3%
▲ +217bp YoY▲ +58bp QoQ
ROE
3.0%
Total Assets
$18.3B
EPS (Diluted)
$3.12
▲ +56.0% YoY▲ +9.9% QoQ
Operating Cash Flow
$387M
▲ +39.6% YoY▼ -37.6% QoQ
Source: XBRL data from Labcorp Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on Labcorp
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.